Video Experimental Relacionado
Updated: Aug 14, 2026
09:44
Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Resumen
La metástasis no es aleatoria, sino que implica el crecimiento selectivo de subpoblaciones especializadas de células cancerosas. Estas células metastásicas poseen propiedades únicas que les permiten completar cada etapa de la cascada metastásica.
Área de la Ciencia:
- Oncología Oncología.
- Biología celular Biología celular.
- Investigación de Investigación del Cáncer.
Sus antecedentes:
- La metástasis es un proceso complejo de varios pasos crucial para la progresión del cáncer y la mortalidad del paciente.
- La visión tradicional sugería la supervivencia celular aleatoria durante la metástasis, pero la evidencia reciente apunta hacia un mecanismo más selectivo.
Objetivo del estudio:
- Investigar los mecanismos celulares subyacentes a las metástasis, desafiando la noción de supervivencia celular aleatoria.
- Identificar las propiedades celulares específicas que facilitan la finalización exitosa de la cascada metastásica.
Principales métodos:
- Este estudio probablemente involucró un análisis comparativo de células tumorales primarias y células metastásicas.
- Los métodos pueden incluir ensayos de cultivo celular in vitro, modelos animales in vivo y perfiles moleculares para identificar características celulares distintas.
Principales resultados:
- La metástasis no surge de la supervivencia aleatoria de las células desprendidas del tumor primario.
- Las células altamente metastásicas son subpoblaciones especializadas con propiedades inherentes que permiten la supervivencia y el crecimiento en cada etapa metastásica.
Conclusiones:
- La metástasis es un proceso selectivo impulsado por subpoblaciones especializadas de células cancerosas.
- Comprender estas propiedades especializadas es clave para desarrollar terapias anti-metastásicas dirigidas.
Videos de Conceptos Relacionados
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...